Byungja Marciante InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on Byungja Marciante, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through Sep 2022 and lists Byungja Marciante's inspections in 23 countries: United States, Korea, Republic Of (South), Australia, Japan, Korea (the Republic of), New Zealand, Germany, Austria, Ireland, Thailand, Czech Republic, Hong Kong SAR, United Kingdom, Italy, China, Romania, Denmark, Switzerland, Greece, Serbia, Sweden, Brazil, and Russia.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Byungja Marciante's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Byungja Marciante.

Product details

• Byungja Marciante's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) Byungja Marciante has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Daniel Skirvin, Anastasia Onuorah, Gabrielle Swain, Marijo Kambere, Charles Bonapace, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.